Delivery Order SPE2DR25D6037-SPE2DR26FXK7M
Award Date 12/18/25
Potential Completion Date 12/19/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This delivery order, awarded June 30, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides for the supply of Belsomra 20 mg tablets (30-count units) with a ceiling value of $1,058.07. The award represents a firm fixed-price delivery order with no set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Belsomra 20 mg tablets (30-count) at a ceiling value of $1,088.22. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is classified as a child contract, meaning it derives from a larger indefinite delivery vehicle. AmerisourceBergen's place of performance is located in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $1,295.84 to AmerisourceBergen Drug Corp for Belsomra 20 mg tablets (30-count) on November 20, 2025, with completion scheduled for November 21, 2025. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical products will be delivered...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,070.75 to AmerisourceBergen Drug Corp for the supply of Belsomra 20 mg tablets (30 count) on December 3, 2025, with completion expected by December 4, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded transaction under DLA's broader pharmaceutical procurement framework. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Belsomra 5 mg tablets (30-count) valued at $1,079.02. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 7, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the contractor's demonstrated capability to compete...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Belsomra 10 mg tablets in a quantity of 30 units, with a ceiling value of $2,550.40. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for completion by November 13, 2025, and represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the...
- The Defense Logistics Agency awarded a $1,185.57 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Belsomra 20 mg, a pharmaceutical product for treating insomnia. This competitively awarded, firm fixed-price contract was issued on September 11, 2025, with an ultimate completion date of September 12, 2025, and involves performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. This delivery...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Belsomra 10mg tablets (30-count) under a firm fixed-price contract valued at $1,072.12. This competitively awarded, non-set-aside delivery order is set to complete by September 3, 2025, with performance occurring at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,179.28 firm fixed price delivery order is for the supply of the prescription medication Belsomra 10 mg tablets. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Belsomra 5 mg tablets, with a ceiling value of $1,836.38 and a completion date of May 26, 2022. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the Department of...